✦ LIBER ✦

Chemotherapy of advanced ovarian adenocarcinoma: A randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin

✍ Scribed by H.J. Solomon; M.H.N. Tattersall; J.J. Campbell; K. Free; D. Humphrey; A. McCartney; G. McLeish; J. Skipper; A.S. Coates; D.R. McNeil; C. Sutherland; C. Swanson; D. Fortune

Book ID: 119052635
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 827 KB
Volume: 23
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(86)90109-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of low- and high-dose cispl

A comparison of low- and high-dose cisplatin-based combination chemotherapy as initial postoperative treatment in advanced ovarian adenocarcinoma

✍ J Menczer; J Brenner; M Modan 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 235 KB

A comparison of low- and high-dose cispl

A comparison of low- and high-dose cisplatin-based combination chemotherapy as initial postoperative treatment in advanced ovarian adenocarcinoma

✍ Menczer, Joseph; Brenner, Joseph; Modan, Michaela; Ben-Baruch, Gilad; Brenner, H 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Long-term survival with advanced ovarian

Long-term survival with advanced ovarian cancer: An analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy

✍ M.H.N. Tattersall; C.E. Swanson; H.J. Solomon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 597 KB

Chemotherapy versus combination of chemo

Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study

✍ G. Cocconi; V. de Lisi; C. Boni; P. Mori; P. Malacarne; D. Amadori; E. Giovanell 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Survival data of a combination versus se

Survival data of a combination versus sequential hormonal therapy and cytotoxic chemotherapy in advanced breast cancel

✍ DavidT. Kiang; B.J. Kennedy 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Advanced ovarian carcinoma: A prospectiv

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques; J. Almeida Ricardo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil (Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently. Objective responses were seen in